课题基金 / 基金详情

Task C13: GMP manufacturing of Oxfendazole clinical trial material and stability study

Task C13: GMP manufacturing of Oxfendazole clinical trial material and stability study
任务C13:奥芬达唑临床试验材料的GMP生产及稳定性研究
批准号:
10475942
负责人:
JON MIRSALIS
金额:
$38.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
未结题
起止时间:
2018-05-01 至 2025-04-30

项目摘要

项目成果

JON MIRSALIS的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The Non-clinical Services for Development of Interventional Agents for Infectious Diseases program provides services to facilitate preclinical product development of promising therapeutics for infectious disease-causing pathogens and/or toxins. Services include: preclinical product development planning and evaluation; lead identification and development; chemistry and GMP manufacturing; in vitro and in vivo preclinical microbiological, safety, toxicology and pharmacokinetics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Task Order D14: Preclinical, Microbiological, Safety, Toxicology, and Pharmacokinetic Services
  • 批准号:
    10901158
  • 项目类别:
  • 资助金额:
    $475.03万
  • 财政年份:
    2023
  • 负责人:
    JON MIRSALIS
  • 依托单位:
Task C19: Recertification for clinical use of GMP Product
  • 批准号:
    10683807
  • 项目类别:
  • 资助金额:
    $15.77万
  • 财政年份:
    2022
  • 负责人:
    JON MIRSALIS
  • 依托单位:
TASK A06: DEVELOPMENT OF A PRECLINICAL NEPHROTOXICITY SCREENING PLAN
  • 批准号:
    10613209
  • 项目类别:
  • 资助金额:
    $4.98万
  • 财政年份:
    2022
  • 负责人:
    JON MIRSALIS
  • 依托单位:
Task C15: APP SYNTHESIS OF YELLOW FEVER COMPOUNDS
  • 批准号:
    10613201
  • 项目类别:
  • 资助金额:
    $12.24万
  • 财政年份:
    2022
  • 负责人:
    JON MIRSALIS
  • 依托单位:
海外基金